In conclusion, increased IL-6, IL-31, IL-1RA, s-IL-6Rα, and s-gp130 in the plasma predicted poorer HNSCC 5-year DSS and OS, as evidenced by the survival analyses. The gene discussed is IL6; the disease is head and neck squamous cell carcinoma.